These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5288787)

  • 1. [Correlation of hydroxyprolinuria and other parameters of bone metabolism].
    Courvoisier B; Zender R
    Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:138-9. PubMed ID: 5288787
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hydroxyprolinuria in skeletal diseases: its correlation with other parameters of bone metabolism].
    Courvoisier B; Zender R
    Schweiz Med Wochenschr; 1972 Feb; 102(5):160-6. PubMed ID: 5010800
    [No Abstract]   [Full Text] [Related]  

  • 3. [Correlations between hydroxyprolinuria and kinetic parameters (Ca45) in bone diseases].
    Gruson M; Miravet L; Hioco D
    Ann Biol Clin (Paris); 1967; 25(5):711-24. PubMed ID: 6059730
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urinary excretion of hydroxyproline as an index of systemic collagen metabolism].
    Drozdz M; Kucharz E
    Pol Tyg Lek; 1972 Oct; 27(42):1655-7. PubMed ID: 4564011
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between bone uptake of 99mTc-pyrophosphate and hydroxyproline in blood and urine.
    Wiegmann T; Kirsh J; Rosenthall L; Kaye M
    J Nucl Med; 1976 Aug; 17(8):711-4. PubMed ID: 180269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Collagen metabolism in children and adolescents with diseases of the skeletal system].
    Balaba TIa; Furtseva LN; Nefed'eva NN
    Ortop Travmatol Protez; 1977 Jul; (7):9-15. PubMed ID: 927794
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hydroxyproline excretion in the urine in destructive bone processes].
    Raab W; Schwägerl W
    Wien Klin Wochenschr; 1967 Jan; 79(2):32-5. PubMed ID: 6031951
    [No Abstract]   [Full Text] [Related]  

  • 8. [Collagen metabolism in patients with bone system tumors].
    Balaba TIa; Zatsepin ST; Furtseva LN
    Vopr Med Khim; 1971; 17(4):388-93. PubMed ID: 5317621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary hydroxyproline and the metabolism of collagen].
    Kivirikko KI
    Duodecim; 1969; 85(18):1108-19. PubMed ID: 5371391
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
    Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
    Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone metabolism and skeletal diseases: general view].
    Grossmann I; Grossmann P
    Z Arztl Fortbild (Jena); 1966 Apr; 60(8):454-64. PubMed ID: 4861717
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in phospho-calcium metabolic factors in function of the rate of bone turnover. Epidemiologic study of osteoporosis (part 2)].
    Maini M; Brignoli E; Felicetti G; Bozzi M
    Minerva Med; 1996 Dec; 87(12):565-76. PubMed ID: 9064593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Collagen and mucopolysaccharides in stroma metabolism].
    Nakagawa T; Iwata H
    Nihon Seikeigeka Gakkai Zasshi; 1970 Sep; 44(9):682-6. PubMed ID: 4250092
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urinary hydroxyproline correlated with quantitative bone histological data. Attempted physiopathological interpretation].
    Lejeune E; Meunier P; Ruitton P; Orgiazzi J
    Rev Rhum Mal Osteoartic; 1972 Feb; 39(2):107-13. PubMed ID: 4343436
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the metabolic osteology].
    Bartelheimer H
    Internist (Berl); 1966 Nov; 7(11):551-2. PubMed ID: 4865828
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term experience with determining metabolic bone collagen grafts and their significance for clinical practice (author's transl)].
    Pacovský V; Hrba J; Formánková J
    Cas Lek Cesk; 1975 Aug; 114(34-35):1063-6. PubMed ID: 1175196
    [No Abstract]   [Full Text] [Related]  

  • 17. The "bone morphogenic proteins" pathways in bone and joint diseases: translational perspectives from physiopathology to therapeutic targets.
    Biver E; Hardouin P; Caverzasio J
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):69-81. PubMed ID: 22749766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between hydroxyprolinuria, alkaline phosphatasemia and Ca45 dynamics].
    Gennari C; Rubegni M; Forconi S; Romano S
    Boll Soc Ital Biol Sper; 1965 May; 41(10):508-12. PubMed ID: 5875588
    [No Abstract]   [Full Text] [Related]  

  • 19. [Techniques for studying collagen in medical practice].
    Borel JP
    Ann Biol Clin (Paris); 1982; 40(5):551-60. PubMed ID: 6760752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cannabinoid receptors in bone disorders: alternatives for treatment.
    Idris AI
    Drug News Perspect; 2008 Dec; 21(10):533-40. PubMed ID: 19221634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.